Pura Vida Investments’s Outset Medical OM Stock Holding History

Pura Vida Investments’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-5,667	Closed	-$925K	–	80
2023 Q3	$925K	Buy	+5,667	New	+$1.34M	0.17%	72
2023 Q1	–	Sell	-25,053	Closed	-$9.7M	–	140
2022 Q4	$9.7M	Buy	+25,053	New	+$7.06M	0.5%	54
2022 Q3	–	Sell	-39,867	Closed	-$8.89M	–	238
2022 Q2	$8.89M	Buy	+39,867	New	+$17.2M	0.52%	55

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Pura Vida Investments's OM Position: Q1 2026 in Review

Pura Vida Investments increased its Outset Medical (OM) stake by 1,567% in Q1 2026, buying an estimated $321K and bringing the position to 83,333 shares worth $320K. The position accounts for 2.15% of the portfolio, ranked #12.

Pura Vida Investments first reported a position in OM in Q3 2020 and has held it in 18 quarters since. The position peaked at $28.6M in Q4 2020. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

Pura Vida Investments held 83,333 shares of Outset Medical worth $320K as of Q1 2026.
Pura Vida Investments bought 78,333 Outset Medical shares in Q1 2026, an estimated $321K.
Outset Medical made up 2.15% of Pura Vida Investments's portfolio in Q1 2026, its #12 holding.
Pura Vida Investments first reported a position in Outset Medical in Q3 2020 and has held it in 18 quarters since.
Pura Vida Investments's Outset Medical position peaked at $28.6M in Q4 2020.
99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Pura Vida Investments's 13F filing for Q1 2026, filed 12 May 2026.